TABLE 4. Spectroscopic Characteristics of Chalcones of the Thiazole Series
Com-
pound
IR spectrum,
1H NMR spectrum, δ, ppm (J, Hz)
νС=О,cm–1
17
18
19
20
21
22
1662
1665
1675
1658
1642
1638
7.64 (1Н, d, J = 15.4, HC=CH); 7.73 (1Н, d, J = 15.4, HC=CH);
7.55-8.12 (5Н, m, Н Ar)
7.63 (1Н, d, J = 15.4, HC=CH); 7.71 (1Н, d, J = 15.4, HC=CH);
7.61-8.13 (4Н, m, Н Ar)
7.62 (1Н, d, J = 15.4, HC=CH); 7.68 (1Н, d, J = 15.4, HC=CH);
7.75-8.04 (4Н, m, Н Ar)
3.86 (3Н, s, OCH3); 7.63 (1Н, d, J = 15.4, HC=CH);
7.73 (1Н, d, J = 15.4, HC=CH); 7.07-8.13 (4Н, m, Н Ar)
3.10 (6Н, s, N(CH3)2); 7.09 (1Н, d, J = 14.7, HC=CH);
7.65 (1Н, d, J = 14.7, HC=CH); 7.48-8.05 (5Н, m, Н Ar)
1.18 (6Н, t, J = 6.9, N(CH2CH3)2); 3.49 (4Н, q, J = 6.9, N(CH2CH3)2);
7.04 (1Н, d, J = 14.7, HC=CH); 7.72 (1Н, d, J = 14.7, HC=CH);
7.49-8.03 (5Н, m, Н Ar)
23
24
25
26
27
1640
1639
1648
1650
1655
1.62 (6Н, s, piperidine); 3.54 (4Н, s, piperidine);
7.02 (1Н, d, J = 14.7, HC=CH); 7.72 (1Н, d, J = 14.7, HC=CH);
7.50-8.02 (5Н, m, Н Ar)
1.61 (6Н, s, piperidine); 3.53 (4Н, s, piperidine);
7.03 (1Н, d, J = 14.6, HC=CH); 7.71 (1Н, d, J = 14.6, HC=CH);
7.56-8.05 (4Н, m, Н Ar)
3.48-3.53 (4Н, m, morpholine); 3.66-3.71 (4Н, m, morpholine);
7.09 (1Н, d, J = 14.6, HC=CH); 7.72 (1Н, d, J = 14.6, HC=CH);
7.48-8.05 (5Н, m, Н Ar)
3.52-3.57 (4Н, m, morpholine); 3.70-3.75 (4Н, m, morpholine);
7.08 (1Н, d, J = 14.6, HC=CH); 7.72 (1Н, d, J = 14.6, HC=CH);
7.54-8.06 (4Н, m, Н Ar)
3.48-3.53 (4Н, m, morpholine); 3.61-3.66 (4Н, m, morpholine);
3.82 (3Н, s, OCH3); 7.12 (1Н, d, J = 14.6, HC=CH);
7.68 (1Н, d, J = 14.6, HC=CH); 7.01-8.05 (4Н, m, Н Ar)
28
29
30
1645
1620
1635
4.10 (3Н, s, OCH3); 7.41 (1Н, d, J = 15.3, HC=CH);
7.68 (1Н, d, J = 15.3, HC=CH); 7.50-8.10 (5Н, m, Н Ar)
3.99 (3Н, s, OCH3); 4.12 (3Н, s, OCH3); 7.41 (1Н, d, J = 15.1, HC=CH);
7.75 (1Н, d, J = 15.1, HC=CH); 7.50-7.80 (5Н, m, Н Ar)
1.61 (6Н, s, piperidine); 3.54 (4Н, s, piperidine); 3.97 (3Н, s, OCH3);
6.54 (1Н, d, J = 14.7, HC=CH); 7.80 (1Н, d, J = 14.7, HC=CH);
7.46-7.93 (5Н, m, Н Ar)
31
1627
3.51-3.55 (4Н, m, morpholine); 3.67-3.72 (4Н, m, morpholine);
3.98 (3Н, s, OCH3); 6.61 (1Н, d, J = 14.6, HC=CH);
7.81 (1Н, d, J = 14.6, HC=CH); 7.43-7.94 (5Н, m, Н Ar)
2,4-Dichloro-1,3-thiazole-5-carbaldehyde (1). DMF (24 g, 0.33 mol) was added dropwise to a
suspension of 1,3-thiazolidine-2,4-dione (35.1 g, 0.3 mol) in phosphorus oxytrichloride (180 ml, 1.8 mol). The
mixture was stirred for 1 h at room temperature, then for 1 h at 80-90°C, after which the mixture was raised to
boiling point and heated for another 4 h. The reaction mixture was poured onto ice (1.5 kg), the aldehyde 1 was
separated by steam distillation. It crystallized on cooling, yield 272.3 g (50%); mp 40°C.
4-Chloro-2-dimethylamino-1,3-thiazole-5-carbaldehyde (2). A solution of dimethylamine (9 g,
0.2 mol) in carbon tetrachloride (50 ml) was added dropwise with stirring and cooling to a solution of
2,3-dichloro-5-formyl-1,3-thiazole (18.2 g, 0.1 mol) in CCl4 (100 ml) and kept at room temperature for 24 h.
The solvent was removed under reduced pressure, the residue was diluted with water, and the precipitate of
aldehyde 2 was filtered off to give a yield of 16.2 g (85%); mp 91°C.
4-Chloro-2-diethylamino-1,3-thiazole-5-carbaldehyde (3). A solution of diethylamine (14.6 g,
0.2 mol) in carbon tetrachloride (50 ml) was added dropwise with stirring and cooling to a solution of
2,3-dichloro-5-formyl-1,3-thiazole (18.2 g, 0.1 mol) in CCl4 (100 ml). The mixture was stirred for a further 2 h
and then kept overnight. The solvent was evaporated, the residue was diluted with water, and the precipitate of
aldehyde 3 was filtered off to give a yield of 18.6 g (85%); mp 112°C.
339